BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 464643)

  • 1. Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
    Ljunggren B; Möller H
    Arch Dermatol Res; 1979 Mar; 264(2):257-60. PubMed ID: 464643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of psoralen and UVA (PUVA) on epidermal melanocytes of the tail in C57BL mice.
    Blog FB; Szabo G
    J Invest Dermatol; 1979 Dec; 73(6):533-7. PubMed ID: 512405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
    Bishop SC
    Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA suppresses the proliferative stimulus produced by stripping on hairless mice.
    Fritsch PO; Gschnait F; Kaaserer G; Brenner W; Chaikittisilpa S; Hönigsmann H; Wolff K
    J Invest Dermatol; 1979 Aug; 73(2):188-90. PubMed ID: 458192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus: association with psoralen--ultraviolet-A treatment of psoriasis.
    Eyanson S; Greist MC; Brandt KD; Skinner B
    Arch Dermatol; 1979 Jan; 115(1):54-6. PubMed ID: 760658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the eyes against damage by light activated psoralen.
    Peek R; Swarbrick P; Stevenson R; Paver K
    Med J Aust; 1979 Feb; 1(4):113-4. PubMed ID: 431454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
    Richard EG
    Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Photochemotherapy with psoralen and ultraviolet A induced apoptosis of NB4 cells and its effects on caspase-8 and caspase-8 protein expressions].
    Sun SJ; Zhao WJ; Xiang Y; Chen NN; Sun F; Chang XH; Cheng YB; Huang SL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):502-5. PubMed ID: 23841272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins in PUVA-treated psoriasis.
    Heiligstädt H; Kassis B; Weismann K; Søndergaad J
    Acta Derm Venereol; 1978; 58(3):213-6. PubMed ID: 78634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoprotective effect of a psoralen-UVA-induced tan.
    Gschnait F; Brenner W; Wolff K
    Arch Dermatol Res; 1978 Nov; 263(2):181-8. PubMed ID: 736602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV.
    Khurshid K; Haroon TS; Hussain I; Pal SS; Jahangir M; Zaman T
    Int J Dermatol; 2000 Nov; 39(11):865-7. PubMed ID: 11123453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus UVA radiation.
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1981 Jun; 76(6):445-8. PubMed ID: 6453906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
    Brücke J; Tanew A; Ortel B; Hönigsmann H
    Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural modification of the plasma membrane in HUT 102 lymphoblasts by long-wave ultraviolet light, psoralen, and PUVA.
    Malinin GI; Lo HK; Hornicek FJ; Malinin TI
    J Invest Dermatol; 1990 Jul; 95(1):97-103. PubMed ID: 2366006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.